Adrenal atrophy laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The labs include random cortisol, serum ACTH, aldosterone and renin, potassium and sodium, ACTH stimulation test and CRH stimulation test. | The labs include random [[cortisol]], serum [[ACTH]], [[aldosterone]] and [[renin]], [[potassium]] and [[sodium]], [[ACTH stimulation test]] and [[CRH stimulation test]]. | ||
==Laboratory findings== | ==Laboratory findings== | ||
Revision as of 04:41, 5 February 2022
|
Adrenal atrophy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenal atrophy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Adrenal atrophy laboratory findings |
|
Risk calculators and risk factors for Adrenal atrophy laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
The labs include random cortisol, serum ACTH, aldosterone and renin, potassium and sodium, ACTH stimulation test and CRH stimulation test.
Laboratory findings
The labs to be run should include:
- random cortisol
- serum ACTH
- aldosterone and renin
- potassium and sodium.
However, in order to check the functionality of the Hypothalamic Pituitary Adrenal Axis the entire axis must be tested by ACTH stimulation test and CRH stimulation test. The ACTH stimulation test consists of injecting a small amount of synthetic ACTH, and the amount of cortisol (and sometimes aldosterone) that the adrenals produce in response is then measured.[1][2]
References
- ↑ Abdu TA, Elhadd TA, Neary R, Clayton RN (March 1999). "Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease". J Clin Endocrinol Metab. 84 (3): 838–43. doi:10.1210/jcem.84.3.5535. PMID 10084558.
- ↑ Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (May 2009). "Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I". J Intern Med. 265 (5): 514–29. doi:10.1111/j.1365-2796.2009.02090.x. PMID 19382991.